SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Sonoma Pharmaceuticals, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.12+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $4.31M
- P/E (TTM)
- –
- Dividend yield
- –
Sonoma Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $5.36M | $230.55M |
| Enterprise Value | $165.04K | $202.97M |
| PS Ratio | 0.24 | 3.11 |
| PB Ratio | 0.81 | 3.14 |
| P/TBV Ratio | 0.81 | 4.57 |
Enterprise value
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| EV / Sales | 0.01 | 2.92 |
Income (trailing twelve months)
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Revenue | $21.92M | $102.39M |
| Gross Profit | $8.53M | $60.36M |
| Operating Income | -$1.41M | -$4.31M |
| Pretax Income | -$2.51M | -$2.26M |
| Net Income | -$2.26M | -$6.57M |
| EBITDA | -$1.27M | -$1.98M |
| EPS (Diluted) | -$1.22 | -$0.07 |
Margins
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Gross Margin | 38.9% | 55.1% |
| Operating Margin | -6.41% | -6.04% |
| Pretax Margin | -11.4% | -4.11% |
| Profit Margin | -10.3% | -10.5% |
| EBITDA Margin | -5.80% | -2.67% |
| FCF Margin | -12.1% | -0.30% |
Returns
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -42.5% | -19.2% |
| Return on Assets (ROA) | -13.8% | -13.3% |
| Return on Invested Capital (ROIC) | -111.9% | -4.11% |
| Return on Capital Employed (ROCE) | -11.1% | -9.07% |
Growth
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 47.0% | 8.85% |
| Revenue Growth (3Y CAGR) | 13.7% | 7.08% |
| Revenue Growth (5Y CAGR) | 0.95% | 11.8% |
Balance sheet
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.34M | $37.33M |
| Total Debt | $140.00K | $72.66M |
| Net Cash (Debt) | $5.20M | $3.92M |
| Net Cash Per Share | $1.09 | $0.28 |
| Equity (Book Value) | $6.59M | $57.36M |
| Book Value Per Share | $1.38 | $2.81 |
| Tangible Book Value | $6.59M | $10.71M |
| Working Capital | $10.82M | $54.64M |
Financial position
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 2.99 | 2.50 |
| Quick Ratio | 1.56 | 1.54 |
| Debt / Equity | 0.02 | 0.38 |
Cash flow (trailing twelve months)
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.57M | -$653.46K |
| Capital Expenditures | -$88.00K | -$3.69M |
| Free Cash Flow | -$2.66M | -$835.02K |
| FCF Per Share | -$0.55 | -$0.02 |
Efficiency
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Asset Turnover | 1.34 | 0.59 |
| Inventory Turnover | 3.53 | 2.21 |
| Revenue Per Employee | $87.68K | $322.57K |
| Profits Per Employee | -$9.06K | -$51.88K |
| Employee Count | 250 | 185 |
Dividends and yields
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -42.2% | -6.91% |
| FCF Yield | -49.5% | -0.56% |
| Buyback Yield | -73.9% | 0.78% |
| Shareholder Yield | -73.9% | 0.80% |
Shares
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 4,788,430 | 44,856,700 |
| Shares Change (YoY) | 55.4% | 3.35% |
| Shares Change (QoQ) | 166.0% | 0.27% |
| Float | 4,257,950 | 37,097,900 |
| Shares Held by Insiders | 11.1% | 10.6% |
| Shares Held by Institutions | 2.31% | 63.5% |
Taxes
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Income Tax | -$243.00K | $1.52M |
Scores
| Measure | Sonoma Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -13.61 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -1.69 | -2.64 |
Calculated by StockData from Sonoma Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.